These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9174248)

  • 1. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.
    Ceresoli G; Guidetti P; Schwarcz R
    Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway.
    Guidetti P; Eastman CL; Schwarcz R
    J Neurochem; 1995 Dec; 65(6):2621-32. PubMed ID: 7595559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.
    Amori L; Guidetti P; Pellicciari R; Kajii Y; Schwarcz R
    J Neurochem; 2009 Apr; 109(2):316-25. PubMed ID: 19226371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitotoxic lesions of the rat striatum: different responses of kynurenine pathway enzymes during ontogeny.
    Ceresoli G; Fuller MS; Schwarcz R
    Brain Res Dev Brain Res; 1996 Mar; 92(1):61-9. PubMed ID: 8861723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
    Ceresoli-Borroni G; Guidetti P; Amori L; Pellicciari R; Schwarcz R
    J Neurosci Res; 2007 Mar; 85(4):845-54. PubMed ID: 17279543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
    Guidetti P; Wu HQ; Schwarcz R
    Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
    Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
    Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.
    Guidetti P; Schwarcz R
    Eur J Neurosci; 1999 Nov; 11(11):3857-63. PubMed ID: 10583474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo.
    Lee SC; Schwarcz R
    Neurosci Lett; 2001 May; 304(3):185-8. PubMed ID: 11343833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central kynurenine pathway shift with age in women.
    de Bie J; Guest J; Guillemin GJ; Grant R
    J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats.
    Ceresoli-Borroni G; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
    Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
    Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
    Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
    Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal asphyxia in rats: acute effects on cerebral kynurenine metabolism.
    Ceresoli-Borroni G; Schwarcz R
    Pediatr Res; 2001 Aug; 50(2):231-5. PubMed ID: 11477208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease?
    Guidetti P; Schwarcz R
    Adv Exp Med Biol; 2003; 527():137-45. PubMed ID: 15206726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.